Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Carlsmed (CARL) Shares Outstanding (Weighted Average) (2024 - 2025)

Carlsmed (CARL) has disclosed Shares Outstanding (Weighted Average) for 2 consecutive years, with $14.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) rose 249.74% year-over-year to $14.2 million, compared with a TTM value of $14.2 million through Dec 2025, up 249.74%, and an annual FY2025 reading of $14.2 million, up 249.74% over the prior year.
  • Shares Outstanding (Weighted Average) was $14.2 million for Q4 2025 at Carlsmed, down from $21.1 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $21.1 million in Q3 2025 and bottomed at $4.0 million in Q2 2024.